SCR-LIP-000431 · Claim · machine-readable JSON →

Multi-omics profiling of late-stage lipedema identified over 5,000 differentially methylated CpG sites and hypomethylation of the AKT1 promoter correlating with increased AKT1 expression and phosphorylation, positioning enhanced AKT pathway signaling as a central epigenetic and molecular alteration rather than a defined germline inheritance pattern.

Claim at a glance

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-08-30

Evidence over time

Santella et al. Journal of Translational Medicine (2026) ✓ verified — refining · cross sectional · 2026 · reading confidence: high
“Genome-wide DNA methylation profiling identified over 5,000 differentially methylated CpG sites affecting genes involved in receptor tyrosine kinase signaling, phospho-metabolism, and immune pathways.”
The article reports epigenetic (DNA methylation) alterations, not germline genetic variants or Mendelian inheritance patterns; it identifies AKT1 promoter hypomethylation rather than a specific inherited variant, so it refines the question

Populationwomen with late-stage lipedema

Conditionlipedema

Exposuremulti-omics profiling (DNA methylation, transcriptomics, metabolomics)

Comparatorcontrols

Outcomedifferentially methylated sites and AKT1 pathway dysregulation

Scopeauto-ingested from Layer 1 surveillance

Auto-ingested single source; not yet human-reviewed.